Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 7/7/14 → 7/7/17 |
Funding
- SynteractHCR, Inc. (Prot #SAV005-02 // Prot #SAV005-02)
- Savara Inc. (Prot #SAV005-02 // Prot #SAV005-02)
Prot #SAV005-02: A Phase 2, randomized, double-blind, placebo-controlled study of AeroVanc for the treatment of persistent methicillin-resistant Staphylococcus aureus lung infection in cystic fibrosis patients
- Jain, Manu (PD/PI)
Project: Research project